{"id":16178,"date":"2020-12-29T09:36:00","date_gmt":"2020-12-29T02:36:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2020122909360016178"},"modified":"2020-12-30T09:14:09","modified_gmt":"2020-12-30T01:14:09","slug":"%e5%92%8c%e9%bb%84%e5%8c%bb%e8%8d%af%e5%bc%80%e5%a7%8b%e5%90%91%e7%be%8e%e5%9b%bdfda%e6%bb%9a%e5%8a%a8%e6%8f%90%e4%ba%a4%e7%b4%a2%e5%87%a1%e6%9b%bf%e5%b0%bc%e6%96%b0%e8%8d%af%e4%b8%8a%e5%b8%82","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2020122909360016178","title":{"rendered":"\u548c\u9ec4\u533b\u836f\u5f00\u59cb\u5411\u7f8e\u56fdFDA\u6eda\u52a8\u63d0\u4ea4\u7d22\u51e1\u66ff\u5c3c\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/www.xinwengao.com\/cn\/wp-content\/uploads\/Hutchison_China_MediTech_Limited_Logo.jpg\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\">\u2013 \u516c\u53f8\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u5b8c\u6210\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u7684\u6eda\u52a8\u63d0\u4ea4 \u2013<br \/>\u2013 SANET-ep \u5173\u952e\u6027 III \u671f\u7814\u7a76\u663e\u793a\uff0c\u7d22\u51e1\u66ff\u5c3c\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe67%\uff0c\u663e\u8457\u5ef6\u957f\u4e86<u>\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624<\/u>\u60a3\u8005\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff0c\u5e76\u5177\u6709\u53ef\u63a5\u53d7\u7684\u98ce\u9669\/\u6536\u76ca\u6bd4&nbsp;\u2013<br \/>\u2013 SANET-p \u5173\u952e\u6027 III \u671f\u7814\u7a76\u663e\u793a\uff0c\u7d22\u51e1\u66ff\u5c3c\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe51%\uff0c\u663e\u8457\u5ef6\u957f\u4e86<u>\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624<\/u>\u60a3\u8005\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff0c\u5e76\u5177\u6709\u53ef\u63a5\u53d7\u7684\u98ce\u9669\/\u6536\u76ca\u6bd4&nbsp;\u2013<br \/>\u2013 \u548c\u9ec4\u533b\u836f\u9996\u6b21\u4e8e\u7f8e\u56fd\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7&nbsp;\u2013<\/p>\n<p><p><span id=\"spanHghlta621\">\u9999\u6e2f\u3001\u4e0a\u6d77\u548c\u7f8e\u56fd\u65b0\u6cfd\u897f\u5ddeFLORHAM PARK\u5e02<\/span>2020\u5e7412\u670829\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;<b>&nbsp;<\/b>\u548c\u9ec4\u4e2d\u56fd\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u7b80\u79f0\u201c<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/%e5%92%8c%e9%bb%84%e4%b8%ad%e5%9b%bd%e5%8c%bb%e8%8d%af%e7%a7%91%e6%8a%80%e6%9c%89%e9%99%90%e5%85%ac%e5%8f%b8\/\" rel=\"nofollow noopener\">\u548c\u9ec4\u533b\u836f<\/a>\u201d\u6216\u201cChi-Med\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240: HCM\uff09\u4eca\u65e5\u5ba3\u5e03\u5df2\u5f00\u59cb\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08&quot;FDA&quot;\uff09\u6eda\u52a8\u63d0\u4ea4\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff08NETs\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08NDA\uff09\u7684\u7b2c\u4e00\u90e8\u5206\uff0c\u5e76\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u5b8c\u6210\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\uff0c\u8fd9\u5c06\u662f\u548c\u9ec4\u533b\u836f\u7684\u9996\u4e2a\u7f8e\u56fd\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<\/p><\/div>\n<p>FDA \u4e8e\u4eca\u5e74\u521d\u6388\u4e88\u7684\u5feb\u901f\u901a\u9053\u8d44\u683c\u5141\u8bb8\u548c\u9ec4\u533b\u836f\u4ee5\u6eda\u52a8\u63d0\u4ea4\u7684\u65b9\u5f0f\u5206\u6279\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u3002\u7d22\u51e1\u66ff\u5c3c\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u662f\u57fa\u4e8e\u7d22\u51e1\u66ff\u5c3c\u4e24\u9879\u6210\u529f\u7684\u4e2d\u56fd III \u671f\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u4e34\u5e8a\u7814\u7a76\uff0c\u4ee5\u53ca\u7d22\u51e1\u66ff\u5c3c\u5728\u7f8e\u56fd\u6cbb\u7597\u975e\u80f0\u817a\u548c\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005<span id=\"spanHghlt95e0\">\u7684\u6570\u636e<\/span>\u652f\u6301\u3002\u548c\u9ec4\u533b\u836f\u6b64\u524d\u5ba3\u5e03\u4e8e<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-plans-to-submit-surufatinib-nda-following-pre-nda-meeting-with-fda\/\" rel=\"nofollow noopener\">\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u524d\uff08pre-NDA\uff09\u4f1a\u8bae<\/a>\u4e0e FDA \u8fbe\u6210\u534f\u8bae\uff0c\u8fd9\u4e9b\u73b0\u6709\u7814\u7a76\u6570\u636e\u53ef\u4f5c\u4e3a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\u7684\u4f9d\u636e\u3002FDA \u4f1a\u4e8e\u6536\u5230\u5b8c\u6574\u7533\u8bf7\u6750\u6599\u540e\u4f1a\u5bf9\u7533\u8bf7\u8fdb\u884c\u5ba1\u67e5\u5e76\u51b3\u5b9a\u662f\u5426\u53d7\u7406\u7533\u8bf7\u3002&nbsp;\u57fa\u4e8e\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08&quot;EMA&quot;\uff09\u7684\u4eba\u7528\u836f\u54c1\u59d4\u5458\u4f1a\uff08CHMP\uff09\u7684<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-plans-to-submit-maa-for-surufatinib\/\" rel=\"nofollow noopener\">\u79d1\u5b66\u5efa\u8bae<\/a>\uff0c\u8fd9\u4e9b\u7814\u7a76\u6570\u636e\u8fd8\u5c06\u7528\u4f5c\u57282021\u5e74\u5411 EMA \u63d0\u4ea4\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\uff08MAA\uff09\u7684\u4f9d\u636e\u3002<\/p>\n<p>\u548c\u9ec4\u533b\u836f\uff08\u56fd\u9645\uff09\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u533b\u5b66\u5b98 <span id=\"spanHghltea5a\"><span class=\"xn-person\">Marek Kania<\/span><\/span> \u8868\u793a\uff1a&quot;\u968f\u7740\u6211\u4eec\u5728\u7f8e\u56fd\u7684\u9996\u4e2a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\u5f00\u59cb\uff0c\u548c\u9ec4\u533b\u836f\u8fdb\u4e00\u6b65\u5b9e\u65bd\u6253\u9020\u5168\u7403\u5316\u751f\u7269\u533b\u836f\u516c\u53f8\u7684\u6218\u7565\uff0c\u5c06\u521b\u65b0\u764c\u75c7\u7597\u6cd5\u5e26\u7ed9\u5168\u7403\u60a3\u8005\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7684\u6cbb\u7597\u4e9f\u5f85\u65b0\u7684\u7597\u6cd5\uff0c\u800c\u7d22\u51e1\u66ff\u5c3c\u5728\u665a\u671f\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u4e2d\u8868\u73b0\u51fa\u663e\u8457\u7684\u4e34\u5e8a\u6536\u76ca\u3002\u6b64\u6b21\u5411\u7f8e\u56fdFDA\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff0c\u6807\u5fd7\u7740\u6211\u4eec\u671d\u5728\u5168\u7403\u8303\u56f4\u5185\u5c06\u7d22\u51e1\u66ff\u5c3c\u548c\u5176\u4ed6\u521b\u65b0\u7597\u6cd5\u5546\u4e1a\u5316\u7684\u76ee\u6807\u8fc8\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002&quot;<\/p>\n<p><span id=\"spanHghltb284\">\u548c\u9ec4\u533b\u836f\u8ba1\u5212\u542f\u52a8\u4e00\u9879\u6269\u5145\u7597\u7a0b\u65b9\u6848\uff0c\u4ee5\u786e\u4fdd\u6cbb\u7597\u9009\u62e9\u6709\u9650\u7684\u60a3\u8005\u80fd\u591f\u83b7\u5f97\u8fd9\u79cd\u91cd\u8981\u7684\u6cbb\u7597\u3002\u4e00\u65e6FDA\u6279\u51c6\u8be5\u65b9\u6848\u7684\u76d1\u7ba1\u8bb8\u53ef\uff0c\u9884\u8ba1\u5c06\u4e8e2021\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5f00\u59cb\u65e9\u671f\u7597\u7a0b\u65b9\u6848\u7684\u6ce8\u518c\u3002<\/span><\/p>\n<p>FDA \u4e8e2020\u5e744\u6708\u6388\u4e88\u7d22\u51e1\u66ff\u5c3c\u4e24\u9879\u5feb\u901f\u901a\u9053\u8d44\u683c\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5e76\u4e8e2019\u5e7411\u6708\u6388\u4e88\u5b64\u513f\u836f\u8d44\u683c\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002<\/p>\n<p><b>\u5173\u4e8e\u795e\u7ecf\u5185\u5206\u6ccc\u7624<\/b><\/p>\n<p>\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff08NET\uff09\u8d77\u6e90\u4e8e\u4e0e\u795e\u7ecf\u7cfb\u7edf\u76f8\u4e92\u4f5c\u7528\u7684\u7ec6\u80de\u6216\u4ea7\u751f\u6fc0\u7d20\u7684\u817a\u4f53\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u53ef\u8d77\u6e90\u4e8e\u4f53\u5185\u5f88\u591a\u90e8\u4f4d\uff0c\u6700\u5e38\u89c1\u4e8e\u6d88\u5316\u9053\u6216\u80ba\u90e8\uff0c\u53ef\u4e3a\u826f\u6027\u6216\u6076\u6027\u80bf\u7624\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u901a\u5e38\u5206\u4e3a\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002\u83b7\u6279\u7684\u9776\u5411\u6cbb\u7597\u5305\u62ec\u7d22\u5766<sup>&reg;<\/sup>\uff08\u82f9\u679c\u9178\u8212\u5c3c\u66ff\u5c3c\uff09\u548c\u98de\u5c3c\u59a5<sup>&reg;<\/sup>\uff08\u4f9d\u7ef4\u83ab\u53f8\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u6216\u9ad8\u5ea6\u5206\u5316\u7684\u975e\u529f\u80fd\u6027\u80c3\u80a0\u9053\u6216\u80ba\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002<\/p>\n<p>\u636e Frost &amp; Sullivan \u516c\u53f8\u4f30\u8ba1\uff0c2018\u5e74\u7f8e\u56fd\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u65b0\u8bca\u65ad\u75c5\u4f8b\u4e3a19,000\u4f8b\u3002\u503c\u5f97\u5173\u6ce8\u7684\u662f\uff0c\u4e0e\u5176\u4ed6\u80bf\u7624\u76f8\u6bd4\uff0c\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u751f\u5b58\u671f\u76f8\u5bf9\u8f83\u957f\u3002\u56e0\u6b64\uff0c\u636e\u4f30\u8ba12018\u5e74\u7f8e\u56fd\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7ea6141,000\u540d\u3002[1]\n<p><b>\u5173\u4e8e\u7d22\u51e1\u66ff\u5c3c<\/b><\/p>\n<p>\u7d22\u51e1\u66ff\u5c3c\uff08surufatinib\uff09\u662f\u4e00\u79cd\u65b0\u578b\u7684\u53e3\u670d\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff0c\u5177\u6709\u6297\u8840\u7ba1\u751f\u6210\u548c\u514d\u75ab\u8c03\u8282\u53cc\u91cd\u6d3b\u6027\u3002\u7d22\u51e1\u66ff\u5c3c\u53ef\u901a\u8fc7\u6291\u5236\u8840\u7ba1\u5185\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08VEGFR\uff09\u548c\u6210\u7ea4\u7ef4\u7ec6\u80de\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08FGFR\uff09\u4ee5\u963b\u65ad\u80bf\u7624\u8840\u7ba1\u751f\u6210\uff0c\u5e76\u53ef\u6291\u5236\u96c6\u843d\u523a\u6fc0\u56e0\u5b501\u53d7\u4f53\uff08CSF-1R\uff09\uff0c\u901a\u8fc7\u8c03\u8282\u80bf\u7624\u76f8\u5173\u5de8\u566c\u7ec6\u80de\uff0c\u4fc3\u8fdb\u673a\u4f53\u5bf9\u80bf\u7624\u7ec6\u80de\u7684\u514d\u75ab\u5e94\u7b54\u3002\u7d22\u51e1\u66ff\u5c3c\u72ec\u7279\u7684\u53cc\u91cd\u673a\u5236\u80fd\u4ea7\u751f\u534f\u540c\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4f7f\u5176\u4e3a\u4e0e\u5176\u4ed6\u514d\u75ab\u7597\u6cd5\u7684\u8054\u5408\u4f7f\u7528\u7684\u7406\u60f3\u9009\u62e9\u3002<\/p>\n<p>\u548c\u9ec4\u533b\u836f\u76ee\u524d\u62e5\u6709\u7d22\u51e1\u66ff\u5c3c\u5728\u5168\u7403\u8303\u56f4\u5185\u7684\u6240\u6709\u6743\u5229\u3002<\/p>\n<p><b>\u7d22\u51e1\u66ff\u5c3c\u5f00\u53d1\u8ba1\u5212<\/b><\/p>\n<p><i>\u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u65e5\u672c\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7814\u7a76\uff1a<\/i>\u5728\u7f8e\u56fd\uff0c\u7d22\u51e1\u66ff\u5c3c\u4e8e2020\u5e744\u6708\u88ab\u6388\u4e88<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-granted-us-fda-fast-track-designations\/\" rel=\"nofollow noopener\">\u5feb\u901f\u901a\u9053\u8d44\u683c<\/a>\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5e76\u4e8e2019\u5e7411\u6708\u88ab\u6388\u4e88\u201c<u><a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-fda-orphan-drug-designation\/\" rel=\"nofollow noopener\">\u5b64\u513f\u836f<\/a><\/u>\u201d\u8d44\u683c\u8ba4\u8bc1\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624&nbsp;\u30022020\u5e7412\u6708\u5df2\u6b63\u5f0f\u63d0\u4ea4\u7f8e\u56fd\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff0c\u5176\u540e\u5c06\u5411\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08EMA\uff09\u63d0\u4ea4\u6b27\u6d32\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\u3002\u4ee5\u4e0a\u7533\u8bf7\u5747\u662f\u57fa\u4e8e\u5df2\u5b8c\u6210\u7684 SANET-ep \u548c SANET-p \u7814\u7a76[2]\uff0c\u4ee5\u53ca\u7d22\u51e1\u66ff\u5c3c\u5728\u7f8e\u56fd\u6cbb\u7597\u975e\u80f0\u817a\u548c\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u73b0\u6709\u6570\u636e\uff08clinicaltrials.gov \u6ce8\u518c\u53f7<a target=\"_blank\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02549937\" rel=\"nofollow noopener\">NCT02549937<\/a>\uff09\u3002<\/p>\n<p><i>\u4e2d\u56fd\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7814\u7a76\uff1a<\/i>2019\u5e7411\u6708\uff0c\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u53d7\u7406\u4e86\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624<u><a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-nda-acceptance\/\" rel=\"nofollow noopener\">\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7<\/a><\/u>\uff0c\u5e76\u4e8e2019\u5e7412\u6708\u7eb3\u5165<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-in-non-pancreatic-net-granted-priority-review-in-china\/\" rel=\"nofollow noopener\">\u4f18\u5148\u5ba1\u8bc4<\/a>\u3002\u8be5\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u83b7\u6210\u529f\u7684 SANET-ep\u7814\u7a76[3]\u6570\u636e\u652f\u6301\u3002SANET-ep \u662f\u4e00\u9879\u5173\u4e8e\u7d22\u51e1\u66ff\u5c3c\u6cbb\u7597\u665a\u671f\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u4e2d\u56fdIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08clinicaltrials.gov \u6ce8\u518c\u53f7<a target=\"_blank\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02588170\" rel=\"nofollow noopener\">NCT02588170<\/a>\uff09\u3002\u8be5\u7814\u7a76\u5728\u8ba1\u5212\u524d\u7684\u4e2d\u671f\u5206\u6790\u6210\u529f\u8fbe\u5230\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08&quot;PFS&quot;\uff09\u8fd9\u4e00\u9884\u8bbe\u4e3b\u8981\u7597\u6548\u7ec8\u70b9\u3002\u8be5\u9879\u7814\u7a76\u7684<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-to-discuss-surufatinib-phase-iii-and-u-s-phase-i-ib-efficacy-and-safety-data-presented-at-the-2019-esmo-annual-meeting\/\" rel=\"nofollow noopener\">\u79ef\u6781\u7ed3\u679c<\/a>\u4e8e2019\u5e74 ESMO \u5e74\u4f1a\u4e0a\u4ee5\u53e3\u5934\u62a5\u544a\u7684\u5f62\u5f0f<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/2019-esmo-annual-meeting\/\" rel=\"nofollow noopener\">\u516c\u5e03<\/a>\uff0c\u5e76\u57282020\u5e749\u6708\u540c\u6b65<a target=\"_blank\" href=\"https:\/\/doi.org\/10.1016\/S1470-2045(20)30496-4\" rel=\"nofollow noopener\">\u53d1\u8868<\/a>\u4e8e\u300a\u67f3\u53f6\u5200&middot;\u80bf\u7624\u5b66\u300b[4]\u3002SANET-ep \u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0c\u7d22\u51e1\u66ff\u5c3c\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe67%\uff0c\u63a5\u53d7\u7d22\u51e1\u66ff\u5c3c\u6cbb\u7597\u60a3\u8005\u7684\u4e2d\u4f4d PFS \u663e\u8457\u5ef6\u957f\u81f39.2\u4e2a\u6708\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u60a3\u8005\u5219\u4e3a3.8\u4e2a\u6708\uff08\u98ce\u9669\u6bd4 [HR] 0.334\uff1b95% \u7f6e\u4fe1\u533a\u95f4 [CI]\uff1a0.223-0.499\uff1b<i>p<\/i>&lt;0.0001\uff09\u3002\u7d22\u51e1\u66ff\u5c3c\u5177\u6709\u53ef\u63a5\u53d7\u7684\u98ce\u9669\/\u6548\u76ca\u6bd4\u3002&nbsp;<\/p>\n<p><i>\u4e2d\u56fd\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7814\u7a76\uff1a<\/i>2016\u5e74\uff0c\u548c\u9ec4\u533b\u836f\u5728\u4e2d\u56fd\u542f\u52a8\u4e86\u4e00\u9879\u5173\u952e\u6027 III \u671f\u6ce8\u518c\u7814\u7a76 SANET-p\uff0c\u5165\u7ec4\u60a3\u8005\u4e3a\u4f4e\u7ea7\u522b\u6216\u4e2d\u7ea7\u522b\u665a\u671f\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u3002\u8be5\u7814\u7a76\u5728\u9884\u8bbe\u7684\u4e2d\u671f\u5206\u6790\u4e2d<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-phase-iii-sanet-p-study-achieved-primary-endpoint\/\" rel=\"nofollow noopener\">\u6210\u529f\u8fbe\u5230PFS\u8fd9\u4e00\u9884\u8bbe\u4e3b\u8981\u7597\u6548\u7ec8\u70b9<\/a>\u5e76\u63d0\u524d\u7ec8\u6b62\u7814\u7a76\uff08clinicaltrials.gov \u6ce8\u518c\u53f7<a target=\"_blank\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02589821\" rel=\"nofollow noopener\">NCT02589821<\/a>\uff09\uff0c\u5e76\u4ee5\u6b64\u4e3a\u57fa\u7840\u4e8e2020\u5e749\u6708\u83b7\u56fd\u5bb6\u836f\u76d1\u5c40<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-announces-second-nda-acceptance-in-china-for-surufatinib-in-pancreatic-net\/\" rel=\"nofollow noopener\">\u53d7\u7406<\/a>\u5176\u7b2c\u4e8c\u9879\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u3002\u8be5\u9879\u7814\u7a76\u7684\u79ef\u6781\u7ed3\u679c\u5df2\u4e8e2020\u5e74 ESMO \u7ebf\u4e0a\u5e74\u4f1a\u4e0a<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/surufatinib-phase-iii-results-at-esmo-2020-and-publications-in-the-lancet-oncology\/\" rel=\"nofollow noopener\">\u516c\u5e03<\/a>\uff0c\u5e76\u540c\u6b65<a target=\"_blank\" href=\"https:\/\/doi.org\/10.1016\/S1470-2045(20)30496-4\" rel=\"nofollow noopener\">\u53d1\u8868<\/a>\u4e8e\u300a\u67f3\u53f6\u5200&middot;\u80bf\u7624\u5b66\u300b[5]\uff0c\u7ed3\u679c\u663e\u793a\u7d22\u51e1\u66ff\u5c3c\u5e2e\u52a9\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe51%\uff0c\u4e2d\u4f4d PFS \u4e3a10.9\u4e2a\u6708\uff0c\u800c\u5b89\u6170\u5242\u5219\u4e3a3.7\u4e2a\u6708\uff08HR 0.491\uff1b95% CI\uff1a0.391-0.755\uff1b<i>p<\/i>=0.0011\uff09\u3002\u7d22\u51e1\u66ff\u5c3c\u7684\u5b89\u5168\u6027\u662f\u53ef\u63a7\u7684\uff0c\u4e0e\u4e4b\u524d\u7814\u7a76\u4e2d\u7684\u89c2\u5bdf\u7ed3\u679c\u4e00\u81f4\u3002<\/p>\n<p><i>\u4e2d\u56fd\u80c6\u9053\u764c\u7814\u7a76\uff1a<\/i>\u548c\u9ec4\u533b\u836f\u4e8e2019\u5e743\u6708\u542f\u52a8\u4e86\u4e00\u9879 IIb\/III \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u65e8\u5728\u5bf9\u6bd4\u7d22\u51e1\u66ff\u5c3c\u548c\u5361\u57f9\u4ed6\u6ee8\u6cbb\u7597\u4e00\u7ebf\u5316\u7597\u5931\u8d25\u665a\u671f\u80c6\u9053\u764c\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u3002\u8be5\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\u4e3a\u603b\u751f\u5b58\u671f\uff08OS\uff09\uff08clinicaltrials.gov \u6ce8\u518c\u53f7\uff1a<a target=\"_blank\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03873532\" rel=\"nofollow noopener\">NCT03873532<\/a>\uff09\u3002<\/p>\n<p><i>\u514d\u75ab\u8054\u5408\u7597\u6cd5\uff1a<\/i>\u548c\u9ec4\u533b\u836f\u8fbe\u6210\u4e86<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/a181129\/\" rel=\"nofollow noopener\">\u6570\u4e2a\u5408\u4f5c\u534f\u8bae<\/a>\uff0c\u4ee5\u8bc4\u4f30\u7d22\u51e1\u66ff\u5c3c\u4e0e PD-1\u5355\u514b\u9686\u6297\u4f53\u8054\u5408\u7597\u6cd5\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u7597\u6548\uff0c\u5305\u62ec\u5df2\u4e8e\u4e2d\u56fd\u83b7\u6279\u7684\u5355\u836f\u7597\u6cd5\u7684<u><a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-and-beigene-collaboration-to-evaluate-surufatinib-and-fruquintinib-with-tislelizumab-combinations\/\" rel=\"nofollow noopener\">\u66ff\u96f7\u5229\u73e0\u5355\u6297<\/a><\/u>\uff08BGB-A317\uff09\u3001<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/chi-med-initiates-a-phase-ii-trial-of-surufatinib-in-combination-with-tuoyi-in-patients-with-advanced-solid-tumors\/\" rel=\"nofollow noopener\">\u62d3\u76ca<\/a><sup>&reg;<\/sup>\uff08\u7279\u745e\u666e\u5229\u5355\u6297\uff09\u548c<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/innovent-and-chi-med-expand-global-collaboration-to-evaluate-the-combination-of-sintilimab-and-surufatinib-in-solid-tumors\/\" rel=\"nofollow noopener\">\u8fbe\u4f2f\u8212<\/a><sup>&reg;<\/sup>\uff08\u4fe1\u8fea\u5229\u5355\u6297\uff09\u3002<\/p>\n<div>\n<table id=\"convertedTable95df\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tbody>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[1] \u636e Frost &amp; Sullivan \u516c\u53f8\u7684\u6570\u636e\uff0c2018\u5e74\u7f8e\u56fd\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u65b0\u8bca\u65ad\u75c5\u4f8b\u4e3a19,000\u4f8b\uff0c\u7f8e\u56fd\u7684\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u603b\u6570\u7ea6\u4e3a141,000\u540d\u3002\u5728\u4e2d\u56fd\u7531\u4e8e\u6cbb\u7597\u624b\u6bb5\u7f3a\u4e4f\uff0c\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7684\u53d1\u75c5\u7387\u4e0e\u6d41\u884c\u7387\u6bd4\u4f8b\u4f30\u8ba1\u4e3a4.4\uff0c\u8f83\u7f8e\u56fd\u76847.4\u4e3a\u4f4e\u3002<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[2] \u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u665a\u671f\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[3] \u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u665a\u671f\u80f0\u817a\u5916\uff08\u975e\u80f0\u817a\uff09\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[4] Xu J, Shen L, Zhou Z, et al. \u7d22\u51e1\u66ff\u5c3c\u5728\u665a\u671f\u80f0\u817a\u5916\u795e\u7ecf\u5185\u5206\u6ccc\u80bf\u7624\uff08SANET-ep\uff09\u4e2d\u7684\u7814\u7a76\uff1a\u4e00\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u76843\u671f\u7814\u7a76[\u5b9e\u4f53\u7248\u53d1\u5e03\u524d\u5728\u7ebf\u53d1\u5e03\uff0c2020\u5e749\u670820\u65e5] \u300a\u67f3\u53f6\u5200&middot;\u80bf\u7624\u5b66\u300b2020\u5e74; S1470-2045(20)30496-4. <a target=\"_blank\" href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(20)30496-4\/fulltext\" class=\"prnews_a\" rel=\"nofollow noopener\">DOI: 10.1016\/S1470-2045(20)30496-4<\/a>\u3002&nbsp;<\/span><span class=\"prnews_span\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">[5] Xu J, Shen L, Bai C, et al. \u7d22\u51e1\u66ff\u5c3c\u5728\u665a\u671f\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u80bf\u7624\uff08SANET-p\uff09\u4e2d\u7684\u7814\u7a76\uff1a\u4e00\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u76843\u671f\u7814\u7a76 [\u5b9e\u4f53\u7248\u53d1\u5e03\u524d\u5728\u7ebf\u53d1\u5e03\uff0c2020\u5e749\u670820\u65e5] \u300a\u67f3\u53f6\u5200&middot;\u80bf\u7624\u5b66\u300b2020\u5e74; S1470-2045(20)30493-9. <a target=\"_blank\" href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(20)30493-9\/fulltext\" class=\"prnews_a\" rel=\"nofollow noopener\">DOI: 10.1016\/S1470-2045(20)30493-9<\/a>\u3002&nbsp;<br \/><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p><b>\u5173\u4e8e\u548c\u9ec4\u533b\u836f<\/b><\/p>\n<p>\u548c\u9ec4\u4e2d\u56fd\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u7b80\u79f0\u201c\u548c\u9ec4\u533b\u836f\u201d\u6216\u201cChi-Med\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240\uff1aHCM\uff09\u662f\u4e00\u5bb6\u5904\u4e8e\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u516c\u53f8\uff0c\u5728\u8fc7\u53bb20\u5e74\u95f4\u81f4\u529b\u4e8e\u53d1\u73b0\u548c\u5168\u7403\u5f00\u53d1\u6cbb\u7597\u764c\u75c7\u548c\u514d\u75ab\u6027\u75be\u75c5\u7684\u9776\u5411\u836f\u7269\u548c\u514d\u75ab\u7597\u6cd5\u3002\u76ee\u524d\uff0c\u548c\u9ec4\u533b\u836f\u5171\u67099\u4e2a\u6297\u764c\u7c7b\u5019\u9009\u836f\u7269\u6b63\u5728\u5168\u7403\u5f00\u53d1\u4e2d\uff0c\u5e76\u5728\u4e2d\u56fd\u672c\u571f\u5e02\u573a\u62e5\u6709\u5e7f\u6cdb\u7684\u5546\u4e1a\u7f51\u7edc\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u8be6\u60c5\uff0c\u8bf7\u8bbf\u95ee\uff1a<a target=\"_blank\" href=\"https:\/\/www.chi-med.com\/sc\/%e5%92%8c%e9%bb%84%e4%b8%ad%e5%9b%bd%e5%8c%bb%e8%8d%af%e7%a7%91%e6%8a%80%e6%9c%89%e9%99%90%e5%85%ac%e5%8f%b8\/\" rel=\"nofollow noopener\">www.chi-med.com<\/a>\u3002<\/p>\n<p><b><i>\u524d\u77bb\u6027\u9648\u8ff0<\/i><\/b><\/p>\n<p><i>\u672c\u65b0\u95fb\u7a3f\u5305\u542b<\/i><i>1995<\/i><i>\u5e74<\/i><i>\u300a<\/i><i>\u7f8e\u56fd\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848<\/i><i>\u300b\u201c<\/i><i>\u5b89\u5168\u6e2f<\/i><i>\u201d<\/i><i>\u6761\u6b3e\u4e2d\u5b9a\u4e49\u7684\u524d\u77bb\u6027\u9648\u8ff0<\/i><i>\u3002<\/i><i>\u8fd9\u4e9b\u524d\u77bb\u6027\u9648\u8ff0\u53cd\u6620\u4e86\u548c\u9ec4\u533b\u836f\u76ee\u524d\u5bf9\u672a\u6765\u4e8b\u4ef6\u7684\u9884\u671f<\/i><i>\uff0c<\/i><i>\u5305\u62ec\u5bf9\u5411<\/i><i>FDA<\/i><i>\u63d0\u4ea4\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u4ee5\u53ca\u63d0\u4ea4\u65f6\u95f4\u7684\u9884\u671f<\/i><i>\uff0c<\/i><span id=\"spanHghlt90f0\"><i>\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u6cbb\u7597\u6f5c\u529b\u7684\u9884\u671f<\/i><i>\u3001<\/i><i>\u7d22\u51e1\u66ff\u5c3c\u9488\u5bf9\u6b64\u9002\u5e94\u75c7\u53ca\u5176\u4ed6\u9002\u5e94\u75c7\u7684\u8fdb\u4e00\u6b65\u4e34\u5e8a\u7814\u7a76\u8ba1\u5212<\/i><i>\u3002<\/i><\/span><i>\u524d\u77bb\u6027\u9648\u8ff0\u6d89\u53ca\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027<\/i><i>\u3002<\/i><i>\u6b64\u7c7b\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u5305\u62ec\u4e0b\u5217\u5047\u8bbe<\/i><i>\uff1a<\/i><i>\u652f\u6301\u7d22\u51e1\u66ff\u5c3c\u83b7\u6279\u7528\u4e8e\u5728\u7f8e\u56fd<\/i><i>\u3001<\/i><i>\u4e2d\u56fd\u53ca\u5176\u4ed6\u5730\u533a\uff08\u5982\u6b27\u6d32\uff09\u6cbb\u7597\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u7684\u6570\u636e\u5145\u8db3\u6027<\/i><i>\u3001<\/i><i>\u83b7\u5f97\u76d1\u7ba1\u90e8\u95e8\u5feb\u901f\u5ba1\u6279\u7684\u6f5c\u529b<\/i><i>\uff0c<\/i><i>\u7d22\u51e1\u66ff\u5c3c\u7684\u5b89\u5168\u6027<\/i><i>\u3002<\/i><i>\u548c\u9ec4\u533b\u836f\u4e3a\u7d22\u51e1\u66ff\u5c3c\u8fdb\u4e00\u6b65\u4e34\u5e8a\u5f00\u53d1\u8ba1\u5212\u63d0\u4f9b\u8d44\u91d1\u5e76\u5b9e\u73b0\u53ca\u5b8c\u6210\u7684\u80fd\u529b<\/i><i>\uff0c<\/i><i>\u6b64\u7c7b\u4e8b\u4ef6\u53d1\u751f\u7684\u65f6\u95f4<\/i><i>\uff0c<\/i><i>\u4ee5\u53ca\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c\u5bf9\u6574\u4f53\u7ecf\u6d4e<\/i><i>\u3001<\/i><i>\u76d1\u7ba1\u53ca\u653f\u6cbb\u72b6\u51b5\u5e26\u6765\u7684\u5f71\u54cd\u7b49<\/i><i>\u3002<\/i><i>\u6b64\u5916<\/i><i>\uff0c<\/i><i>\u7531\u4e8e\u90e8\u5206\u7814\u7a76\u8d56\u4e8e\u5c06\u5361\u57f9\u4ed6\u6ee8<\/i><i>\u3001<\/i><i>\u66ff\u96f7\u5229\u73e0\u5355\u6297<\/i><i>\u3001<\/i><i>\u62d3\u76ca<\/i><i>&reg;\u3001<\/i><i>\u8fbe\u4f2f\u8212<\/i><i>&reg;<\/i><i>\u4e0e\u7d22\u51e1\u66ff\u5c3c\u8054\u5408\u4f7f\u7528<\/i><i>\uff0c<\/i><i>\u56e0\u6b64\u6b64\u7c7b\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u5305\u62ec\u6709\u5173\u8fd9\u4e9b\u6cbb\u7597\u836f\u7269\u7684\u5b89\u5168\u6027<\/i><i>\u3001<\/i><i>\u7597\u6548<\/i><i>\u3001<\/i><i>\u4f9b\u5e94\u548c\u76d1\u7ba1\u6279\u51c6\u7684\u5047\u8bbe<\/i><i>\u3002<\/i><i>\u5f53\u524d\u548c\u6f5c\u5728\u6295\u8d44\u8005\u8bf7\u52ff\u8fc7\u5ea6\u4f9d\u8d56\u8fd9\u4e9b\u524d\u77bb\u6027\u9648\u8ff0<\/i><i>\uff0c<\/i><i>\u8fd9\u4e9b\u9648\u8ff0\u4ec5\u5728\u622a\u81f3\u672c\u516c\u544a\u53d1\u5e03\u5f53\u65e5\u6709\u6548<\/i><i>\u3002<\/i><i>\u6709\u5173\u8fd9\u4e9b\u98ce\u9669\u548c\u5176\u4ed6\u98ce\u9669\u7684\u8fdb\u4e00\u6b65\u8ba8\u8bba<\/i><i>\uff0c<\/i><i>\u8bf7\u67e5\u9605\u548c\u9ec4\u533b\u836f\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u548c <\/i><i>AIM <\/i><i>\u63d0\u4ea4\u7684\u6587\u4ef6<\/i><i>\u3002<\/i><i>\u65e0\u8bba\u662f\u5426\u51fa\u73b0\u65b0\u4fe1\u606f<\/i><i>\u3001<\/i><i>\u672a\u6765\u4e8b\u4ef6\u6216\u60c5\u51b5\u6216\u5176\u4ed6\u56e0\u7d20<\/i><i>\uff0c<\/i><i>\u548c\u9ec4\u533b\u836f\u5747\u4e0d\u627f\u62c5\u66f4\u65b0\u6216\u4fee\u8ba2\u672c\u65b0\u95fb\u7a3f\u6240\u542b\u4fe1\u606f\u7684\u4e49\u52a1<\/i><i>\u3002<\/i><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">  <\/div>\n<p>\u76f8\u5173\u94fe\u63a5 :<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"mu9qg82Mfv\"><p><a href=\"https:\/\/www.chi-med.com\/\">Home<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Home&#8221; &#8212; Chi-Med\" src=\"https:\/\/www.chi-med.com\/embed\/#?secret=mu9qg82Mfv\" data-secret=\"mu9qg82Mfv\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2013 \u516c\u53f8\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u5b8c\u6210\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u7684\u6eda\u52a8\u63d0\u4ea4 \u2013\u2013 SANET-ep \u5173\u952e\u6027 III \u671f\u7814\u7a76\u663e\u793a\uff0c\u7d22\u51e1\u66ff\u5c3c\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe67%\uff0c\u663e\u8457\u5ef6\u957f\u4e86\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff0c\u5e76\u5177\u6709\u53ef\u63a5\u53d7\u7684\u98ce\u9669\/\u6536\u76ca\u6bd4&nbsp;\u2013\u2013 SANET-p \u5173\u952e\u6027 III \u671f\u7814\u7a76\u663e\u793a\uff0c\u7d22\u51e1\u66ff\u5c3c\u964d\u4f4e\u60a3\u8005\u7684\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u8fbe51%\uff0c\u663e\u8457\u5ef6\u957f\u4e86\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff0c\u5e76\u5177\u6709\u53ef\u63a5\u53d7\u7684\u98ce\u9669\/\u6536\u76ca\u6bd4&nbsp;\u2013\u2013 \u548c\u9ec4\u533b\u836f\u9996\u6b21\u4e8e\u7f8e\u56fd\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7&nbsp;\u2013 \u9999\u6e2f\u3001\u4e0a\u6d77\u548c\u7f8e\u56fd\u65b0\u6cfd\u897f\u5ddeFLORHAM PARK\u5e022020\u5e7412\u670829\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;&nbsp;\u548c\u9ec4\u4e2d\u56fd\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u7b80\u79f0\u201c\u548c\u9ec4\u533b\u836f\u201d\u6216\u201cChi-Med\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\/\u4f26\u6566\u8bc1\u4ea4\u6240: HCM\uff09\u4eca\u65e5\u5ba3\u5e03\u5df2\u5f00\u59cb\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08&quot;FDA&quot;\uff09\u6eda\u52a8\u63d0\u4ea4\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff08NETs\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08NDA\uff09\u7684\u7b2c\u4e00\u90e8\u5206\uff0c\u5e76\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u5b8c\u6210\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\uff0c\u8fd9\u5c06\u662f\u548c\u9ec4\u533b\u836f\u7684\u9996\u4e2a\u7f8e\u56fd\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u3002 FDA \u4e8e\u4eca\u5e74\u521d\u6388\u4e88\u7684\u5feb\u901f\u901a\u9053\u8d44\u683c\u5141\u8bb8\u548c\u9ec4\u533b\u836f\u4ee5\u6eda\u52a8\u63d0\u4ea4\u7684\u65b9\u5f0f\u5206\u6279\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u3002\u7d22\u51e1\u66ff\u5c3c\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u662f\u57fa\u4e8e\u7d22\u51e1\u66ff\u5c3c\u4e24\u9879\u6210\u529f\u7684\u4e2d\u56fd III \u671f\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u4e34\u5e8a\u7814\u7a76\uff0c\u4ee5\u53ca\u7d22\u51e1\u66ff\u5c3c\u5728\u7f8e\u56fd\u6cbb\u7597\u975e\u80f0\u817a\u548c\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u6570\u636e\u652f\u6301\u3002\u548c\u9ec4\u533b\u836f\u6b64\u524d\u5ba3\u5e03\u4e8e\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u524d\uff08pre-NDA\uff09\u4f1a\u8bae\u4e0e FDA \u8fbe\u6210\u534f\u8bae\uff0c\u8fd9\u4e9b\u73b0\u6709\u7814\u7a76\u6570\u636e\u53ef\u4f5c\u4e3a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\u7684\u4f9d\u636e\u3002FDA \u4f1a\u4e8e\u6536\u5230\u5b8c\u6574\u7533\u8bf7\u6750\u6599\u540e\u4f1a\u5bf9\u7533\u8bf7\u8fdb\u884c\u5ba1\u67e5\u5e76\u51b3\u5b9a\u662f\u5426\u53d7\u7406\u7533\u8bf7\u3002&nbsp;\u57fa\u4e8e\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08&quot;EMA&quot;\uff09\u7684\u4eba\u7528\u836f\u54c1\u59d4\u5458\u4f1a\uff08CHMP\uff09\u7684\u79d1\u5b66\u5efa\u8bae\uff0c\u8fd9\u4e9b\u7814\u7a76\u6570\u636e\u8fd8\u5c06\u7528\u4f5c\u57282021\u5e74\u5411 EMA \u63d0\u4ea4\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\uff08MAA\uff09\u7684\u4f9d\u636e\u3002 \u548c\u9ec4\u533b\u836f\uff08\u56fd\u9645\uff09\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u533b\u5b66\u5b98 Marek Kania \u8868\u793a\uff1a&quot;\u968f\u7740\u6211\u4eec\u5728\u7f8e\u56fd\u7684\u9996\u4e2a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u63d0\u4ea4\u5f00\u59cb\uff0c\u548c\u9ec4\u533b\u836f\u8fdb\u4e00\u6b65\u5b9e\u65bd\u6253\u9020\u5168\u7403\u5316\u751f\u7269\u533b\u836f\u516c\u53f8\u7684\u6218\u7565\uff0c\u5c06\u521b\u65b0\u764c\u75c7\u7597\u6cd5\u5e26\u7ed9\u5168\u7403\u60a3\u8005\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7684\u6cbb\u7597\u4e9f\u5f85\u65b0\u7684\u7597\u6cd5\uff0c\u800c\u7d22\u51e1\u66ff\u5c3c\u5728\u665a\u671f\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u4e2d\u8868\u73b0\u51fa\u663e\u8457\u7684\u4e34\u5e8a\u6536\u76ca\u3002\u6b64\u6b21\u5411\u7f8e\u56fdFDA\u63d0\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff0c\u6807\u5fd7\u7740\u6211\u4eec\u671d\u5728\u5168\u7403\u8303\u56f4\u5185\u5c06\u7d22\u51e1\u66ff\u5c3c\u548c\u5176\u4ed6\u521b\u65b0\u7597\u6cd5\u5546\u4e1a\u5316\u7684\u76ee\u6807\u8fc8\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002&quot; \u548c\u9ec4\u533b\u836f\u8ba1\u5212\u542f\u52a8\u4e00\u9879\u6269\u5145\u7597\u7a0b\u65b9\u6848\uff0c\u4ee5\u786e\u4fdd\u6cbb\u7597\u9009\u62e9\u6709\u9650\u7684\u60a3\u8005\u80fd\u591f\u83b7\u5f97\u8fd9\u79cd\u91cd\u8981\u7684\u6cbb\u7597\u3002\u4e00\u65e6FDA\u6279\u51c6\u8be5\u65b9\u6848\u7684\u76d1\u7ba1\u8bb8\u53ef\uff0c\u9884\u8ba1\u5c06\u4e8e2021\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5f00\u59cb\u65e9\u671f\u7597\u7a0b\u65b9\u6848\u7684\u6ce8\u518c\u3002 FDA \u4e8e2020\u5e744\u6708\u6388\u4e88\u7d22\u51e1\u66ff\u5c3c\u4e24\u9879\u5feb\u901f\u901a\u9053\u8d44\u683c\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5e76\u4e8e2019\u5e7411\u6708\u6388\u4e88\u5b64\u513f\u836f\u8d44\u683c\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002 \u5173\u4e8e\u795e\u7ecf\u5185\u5206\u6ccc\u7624 \u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff08NET\uff09\u8d77\u6e90\u4e8e\u4e0e\u795e\u7ecf\u7cfb\u7edf\u76f8\u4e92\u4f5c\u7528\u7684\u7ec6\u80de\u6216\u4ea7\u751f\u6fc0\u7d20\u7684\u817a\u4f53\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u53ef\u8d77\u6e90\u4e8e\u4f53\u5185\u5f88\u591a\u90e8\u4f4d\uff0c\u6700\u5e38\u89c1\u4e8e\u6d88\u5316\u9053\u6216\u80ba\u90e8\uff0c\u53ef\u4e3a\u826f\u6027\u6216\u6076\u6027\u80bf\u7624\u3002\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u901a\u5e38\u5206\u4e3a\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002\u83b7\u6279\u7684\u9776\u5411\u6cbb\u7597\u5305\u62ec\u7d22\u5766&reg;\uff08\u82f9\u679c\u9178\u8212\u5c3c\u66ff\u5c3c\uff09\u548c\u98de\u5c3c\u59a5&reg;\uff08\u4f9d\u7ef4\u83ab\u53f8\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u6216\u9ad8\u5ea6\u5206\u5316\u7684\u975e\u529f\u80fd\u6027\u80c3\u80a0\u9053\u6216\u80ba\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u3002 \u636e Frost &amp; Sullivan \u516c\u53f8\u4f30\u8ba1\uff0c2018\u5e74\u7f8e\u56fd\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u65b0\u8bca\u65ad\u75c5\u4f8b\u4e3a19,000\u4f8b\u3002\u503c\u5f97\u5173\u6ce8\u7684\u662f\uff0c\u4e0e\u5176\u4ed6\u80bf\u7624\u76f8\u6bd4\uff0c\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u751f\u5b58\u671f\u76f8\u5bf9\u8f83\u957f\u3002\u56e0\u6b64\uff0c\u636e\u4f30\u8ba12018\u5e74\u7f8e\u56fd\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7ea6141,000\u540d\u3002[1] \u5173\u4e8e\u7d22\u51e1\u66ff\u5c3c \u7d22\u51e1\u66ff\u5c3c\uff08surufatinib\uff09\u662f\u4e00\u79cd\u65b0\u578b\u7684\u53e3\u670d\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff0c\u5177\u6709\u6297\u8840\u7ba1\u751f\u6210\u548c\u514d\u75ab\u8c03\u8282\u53cc\u91cd\u6d3b\u6027\u3002\u7d22\u51e1\u66ff\u5c3c\u53ef\u901a\u8fc7\u6291\u5236\u8840\u7ba1\u5185\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08VEGFR\uff09\u548c\u6210\u7ea4\u7ef4\u7ec6\u80de\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08FGFR\uff09\u4ee5\u963b\u65ad\u80bf\u7624\u8840\u7ba1\u751f\u6210\uff0c\u5e76\u53ef\u6291\u5236\u96c6\u843d\u523a\u6fc0\u56e0\u5b501\u53d7\u4f53\uff08CSF-1R\uff09\uff0c\u901a\u8fc7\u8c03\u8282\u80bf\u7624\u76f8\u5173\u5de8\u566c\u7ec6\u80de\uff0c\u4fc3\u8fdb\u673a\u4f53\u5bf9\u80bf\u7624\u7ec6\u80de\u7684\u514d\u75ab\u5e94\u7b54\u3002\u7d22\u51e1\u66ff\u5c3c\u72ec\u7279\u7684\u53cc\u91cd\u673a\u5236\u80fd\u4ea7\u751f\u534f\u540c\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4f7f\u5176\u4e3a\u4e0e\u5176\u4ed6\u514d\u75ab\u7597\u6cd5\u7684\u8054\u5408\u4f7f\u7528\u7684\u7406\u60f3\u9009\u62e9\u3002 \u548c\u9ec4\u533b\u836f\u76ee\u524d\u62e5\u6709\u7d22\u51e1\u66ff\u5c3c\u5728\u5168\u7403\u8303\u56f4\u5185\u7684\u6240\u6709\u6743\u5229\u3002 \u7d22\u51e1\u66ff\u5c3c\u5f00\u53d1\u8ba1\u5212 \u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u65e5\u672c\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7814\u7a76\uff1a\u5728\u7f8e\u56fd\uff0c\u7d22\u51e1\u66ff\u5c3c\u4e8e2020\u5e744\u6708\u88ab\u6388\u4e88\u5feb\u901f\u901a\u9053\u8d44\u683c\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u548c\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5e76\u4e8e2019\u5e7411\u6708\u88ab\u6388\u4e88\u201c\u5b64\u513f\u836f\u201d\u8d44\u683c\u8ba4\u8bc1\uff0c\u7528\u4e8e\u6cbb\u7597\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624&nbsp;\u30022020\u5e7412\u6708\u5df2\u6b63\u5f0f\u63d0\u4ea4\u7f8e\u56fd\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff0c\u5176\u540e\u5c06\u5411\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08EMA\uff09\u63d0\u4ea4\u6b27\u6d32\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\u3002\u4ee5\u4e0a\u7533\u8bf7\u5747\u662f\u57fa\u4e8e\u5df2\u5b8c\u6210\u7684 SANET-ep \u548c SANET-p \u7814\u7a76[2]\uff0c\u4ee5\u53ca\u7d22\u51e1\u66ff\u5c3c\u5728\u7f8e\u56fd\u6cbb\u7597\u975e\u80f0\u817a\u548c\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u73b0\u6709\u6570\u636e\uff08clinicaltrials.gov \u6ce8\u518c\u53f7NCT02549937\uff09\u3002 \u4e2d\u56fd\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u7814\u7a76\uff1a2019\u5e7411\u6708\uff0c\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u53d7\u7406\u4e86\u7d22\u51e1\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff0c\u5e76\u4e8e2019\u5e7412\u6708\u7eb3\u5165\u4f18\u5148\u5ba1\u8bc4\u3002\u8be5\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\u83b7\u6210\u529f\u7684 SANET-ep\u7814\u7a76[3]\u6570\u636e\u652f\u6301\u3002SANET-ep \u662f\u4e00\u9879\u5173\u4e8e\u7d22\u51e1\u66ff\u5c3c\u6cbb\u7597\u665a\u671f\u975e\u80f0\u817a\u795e\u7ecf\u5185\u5206\u6ccc\u7624\u60a3\u8005\u7684\u4e2d\u56fdIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08clinicaltrials.gov \u6ce8\u518c\u53f7NCT02588170\uff09\u3002\u8be5\u7814\u7a76\u5728\u8ba1\u5212\u524d\u7684\u4e2d\u671f\u5206\u6790\u6210\u529f\u8fbe\u5230\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08&quot;PFS&quot;\uff09\u8fd9\u4e00\u9884\u8bbe\u4e3b\u8981\u7597\u6548\u7ec8\u70b9\u3002\u8be5\u9879\u7814\u7a76\u7684\u79ef\u6781\u7ed3\u679c\u4e8e2019\u5e74 ESMO&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2020122909360016178\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":16181,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-16178","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/16178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=16178"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/16178\/revisions"}],"predecessor-version":[{"id":16180,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/16178\/revisions\/16180"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/16181"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=16178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=16178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=16178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}